What dose does this Tesamorelin calculator use by default?

It starts from the first supported mg/mcg protocol in the MeinePeptide monograph, preferring beginner, then standard, then advanced protocols.

How much bacteriostatic water should I compare?

The chart compares 1 ml, 2 ml, and 3 ml because these are common reconstitution volumes. The interactive calculator lets you enter any volume.

Does it work for non-HIV users?

Mechanistically yes, and the off-label community track record supports a similar visceral-fat effect. There is no dedicated phase-3 trial in non-HIV populations, so the evidence is borrowed. Most experienced users see a measurable waistline change by week 12 if they are also not gaining subcutaneous fat from a calorie surplus.

How long does the benefit last after I stop?

Phase-3 extension data shows that stopping tesamorelin allows visceral fat to gradually return over months. This is not a one-and-done protocol — sustaining the benefit requires either continued low-dose maintenance or sustained lifestyle factors (calorie balance, cardio, sleep) that keep visceral fat suppressed on their own.

Back to TesamorelinPeptide-specific calculator

Tesamorelin dosage calculator

Calculate Tesamorelin concentration, syringe units, doses per vial, and vial longevity from the protocol data.

Target dose per injection: 1 mgFrequency: DailyStatic chart: 5 mg vial

The chart is educational math only. Use clinician-directed instructions for real treatment decisions.

Prefilled calculator

Reconstitution & dosage calculator

Use the prefilled calculator for the current protocol, then compare common bacteriostatic-water volumes in the static chart below.

Peptide

Peptide quantity (mg)

Bacteriostatic water (ml)

Target dose per injection

Unit

Frequency

Syringe size

Concentration

2.5 mg/ml

Units to draw per dose40

ml per dose0.4 ml

Doses per vial5

Days a vial lasts5

Syringe

Fill to 40 units on a 1 ml syringe.

Static chart: 5 mg vial

Reconstitution chart

Common bacteriostatic-water options for the starting protocol.

Bacteriostatic water (ml)	Concentration	Units to draw per dose	ml per dose	Doses per vial	Days a vial lasts
1 ml	5 mg/ml	20	0.2 ml	5	5
2 ml	2.5 mg/ml	40	0.4 ml	5	5
3 ml	1.667 mg/ml	60	0.6 ml	5	5

Protocol table

Advanced

2 mg

once daily

Routesubcut

Injection timing26 weeks on / 8 weeks off

Specifically reduces visceral adipose tissue.

Beginner

1 mg

once daily

Routesubcut

Injection timing12 weeks on / 4 weeks off

Standard

2 mg

once daily

Routesubcut

Injection timing16 weeks on / 4 weeks off

Safety summary

Contraindications

Active cancer or recent cancer history — GH/IGF-1 elevation is a contraindicated mechanism
Pregnancy or breastfeeding (Pregnancy Category X)
Severe diabetic retinopathy — the GH axis worsens microvascular disease
Severe uncontrolled diabetes — glucose effect compounds the underlying problem
Hypopituitarism without endocrinologist oversight

Side effects

mildJoint aches, particularly hands and wrists. Resolve within a week of dose reduction.
mildCarpal-tunnel-like tingling in fingers. Common with any GH-axis amplification; reversible.
mildMild peripheral oedema in the first 2–3 weeks.
moderateElevated fasting glucose at 2 mg/day. Check fasting glucose and HbA1c at 8 and 16 weeks.
moderateInjection-site reactions — small red bumps that resolve over 24–48 hours. Rotate sites.

Tesamorelin

A stabilised GHRH analogue with an FDA approval for HIV-associated lipodystrophy — the only growth-hormone-axis secretagogue with a genuine regulatory signal. Famous for selectively shrinking visceral fat.

Read full monograph